The importance of being grade 3 in primary non-muscle invasive bladder cancer

The importance of being grade 3 in primary non-muscle invasive bladder cancer

Bibliographic Details
Main Authors:	B.W.G. Van Rhijn, I.J. Beijert, P. Mariappan, F. Liedberg
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168324002866

Similar Items

Identifying changes in the tumor micro-environment in muscle-invasive bladder cancer after neo-adjuvant chemotherapy
by: J. van Dorp, et al.
Published: (2020-07-01)

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future
by: Hermans, TJN, et al.
Published: (2017)

839 Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer
by: Peter Ellmark, et al.
Published: (2020-11-01)

Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer
by: C.S. Voskuilen, et al.
Published: (2020-07-01)

Recommendations for follow-up of muscle-invasive bladder cancer patients: A consensus by the international bladder cancer network
by: Zuiverloon, TCM, et al.
Published: (2018)

The Effects of Histological Grade Ratio on The Progression of High-Grade Non-Muscle Invasive Bladder Tumors
by: Meltem ÖZNUR, et al.
Published: (2020-08-01)

Risk tables for predicting progression using the 1973 and 2004/2016 WHO grading classification systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study
by: R.J. Sylvester, et al.
Published: (2020-07-01)

Endothelin-1 indicates unfavorable prognosis in primary high-grade non-muscle-invasive urothelial bladder cancer
by: Lampros Mitrakas, et al.
Published: (2021-06-01)

Validation of the importance of neutrophil-to-lymphocyte ratio in non-muscle invasive bladder cancer
by: Porav-Hodade Daniel, et al.
Published: (2022-02-01)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
by: Nessn Azawi, et al.
Published: (2023-04-01)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
by: Longchao Li, et al.
Published: (2023-03-01)

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer.
by: Lars Holmberg, et al.
Published: (2022-01-01)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
by: Nico C. Grossmann, et al.
Published: (2022-05-01)

Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
by: Kristin Grabe-Heyne, et al.
Published: (2023-06-01)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
by: David D'Andrea, et al.
Published: (2022-07-01)

BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets
by: Francesco Claps, et al.
Published: (2023-08-01)

Non-muscle invasive bladder cancer risk stratification
by: Sumit Isharwal, et al.
Published: (2015-01-01)

Latent heterogeneity of muscle‐invasive bladder cancer in patient characteristics and survival: A population‐based nation‐wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)
by: Christel Häggström, et al.
Published: (2023-06-01)

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
by: Yun Seok-Joong, et al.
Published: (2010-01-01)

History of infantile BCG immunization did not predict lamina propria invasion and/or high-grade in patients with non-muscle invasive bladder cancer
by: Anastasia MacDonald, et al.
Published: (2023-05-01)

Comparison of holmium laser, bipolar and conventional monopolar transurethral resection of bladder tumour in primary non-muscle invasive bladder cancer
by: Salah Elmekawy, et al.
Published: (2023-05-01)

Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
by: Myung-Shin Lee, et al.
Published: (2015-01-01)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
by: Weizhuo Wang, et al.
Published: (2023-08-01)

Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer. NEJM Evid. In press. https://doi.org/10.1056/EVIDoa2200092
by: Fredrik Liedberg, et al.
Published: (2022-12-01)

TREATMENT OF NON-MUSCLE-INVASIVE HIGH-RISK BLADDER CANCER
by: S. A. Ivanov, et al.
Published: (2017-07-01)

Fluorescence cystoscopy in patients with non-muscle invasive bladder cancer
by: I. G. Rusakov, et al.
Published: (2015-09-01)

Repeated transurethral resection in non-muscle invasive bladder cancer
by: Ivan VLADANOV, et al.
Published: (2021-03-01)

Are we following the guidelines on non-muscle invasive bladder cancer?
by: Leonardo Oliveira Reis, et al.
Published: (2016-02-01)

Non-muscle invasive bladder cancer biomarkers beyond morphology
by: Camilla De Carlo, et al.
Published: (2022-08-01)

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
by: K. M. Patel, et al.
Published: (2017-07-01)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
by: Gottfrid Sjödahl, et al.
Published: (2022-03-01)

Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based cohort study
by: Christel Häggström, et al.
Published: (2019-05-01)

Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
by: Daniele Minardi, et al.
Published: (2016-03-01)

Evaluation of tissue and urinary survivin expression in non-muscle-invasive bladder cancer
by: S. Sharaf, et al.
Published: (2012-12-01)

NON-INVASIVE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER IN PATIENTS WITH DERANGED RENAL PROFILE
by: Muhammad Adnan Zeb, et al.
Published: (2018-12-01)

The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs
by: Emrah Yuruk, et al.

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
by: Joep J. de Jong, et al.
Published: (2019-10-01)

Update on the potential role of micro-ultrasound in the differentiation between muscle-invasive and non-muscle invasive bladder cancer
by: A. Uleri, et al.
Published: (2020-10-01)

A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging.
by: Chuanliang Xu, et al.
Published: (2014-01-01)

Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.
by: Won Tae Kim, et al.
Published: (2010-01-01)